found 84.5%, 85%, and 87.5% accuracy in coding 522 ECGs using three diVerent manual approaches where the gold standard reflected consensus among the six approaches. Three automated techniques had accuracies of 55.2%, 77.3%, and 77.9% in the same test. With more recently developed automated methods, 10 repeat codings showed discrepancies in 16% for ECGs recorded 15-30 minutes apart using marked electrode positions and in 19% for ECGs recorded 2-3 weeks apart.
Minnesota Code
The Minnesota Code 6 itself does not produce an interpretation of an ECG but, rather, provides a classification of electrocardiographic morphology on the basis of rigid criteria-for example, Q duration in lead II > 40 ms constitutes a code 1-1-2 (posterior), where a Q wave is defined as a negative wave that is followed by a positive (R) wave of defined minimum amplitude and duration. Thus, for example, a QS complex of any duration in lead II does not constitute a code 1-1-2. Codes 1-that is, codes beginning with 1-deal with Q waves of varying duration and amplitude in a hierarchical way with codes 1-1-x (where x = 1, 2 . . .7) generally representing Q waves of larger magnitude, and hence clinical significance, than codes 1-2-y (where y = 1, 2 . . .8) which in turn are more significant than codes 1-3-z (where z = 1, 2 . . .6). Table 1 broadly summarises the codes. As another example, a clearly inverted T wave in V3 might be classified as 5-2 (anterior) in the presence of a QRS complex with normal duration. The exceptions to the application of criteria for pattern recognition are the WolV-Parkinson-White (WPW) pattern and arrhythmias, which require to be interpreted by a reviewer who then assigns the relevant code-for example, atrial fibrillation is coded as 8-3-1.
While codes 1 are often mapped to a diagnosis of myocardial infarction, with, for example, 1-1-1 being regarded as diagnostic and 1-3-4 as possible myocardial infarction, the Minnesota Code per se does not draw such conclusions. Similarly, while 5-2 might be interpreted as a pattern that provides evidence of ischaemic heart disease in population studies such as that in this issue, 3 some cardiologists might argue that this is an unreliable approach to adopt, given the many causes of T wave change.
The code itself has several deficiencies. For example, the criteria for high voltage are neither age nor sex dependent and it is well known that such criteria indeed should be so, given the current state of knowledge of the normal limits of the 12 lead ECG . 11 As another example, the code does not classify low R waves in the precordial leads apart from reversed R wave progression.
It would be fair to say that most cardiologists are not conversant with the Minnesota Code and, indeed, need not be in terms of daily clinical routine. The code itself has remained essentially unchanged through the years and only in recent times has there been any attempt to produce an alternative approach, as was done by Rautaharju (one of the authors of the original Minnesota Code) and colleagues. 12 The benefit of Minnesota coding lies in its reputed ability to aVord an objective comparison of findings in various populations independent of the more subjective views of individual cardiologists who might be called upon to report an ECG. Furthermore, in clinical trials such as the West of Scotland Coronary Prevention Study (WOSCOPS), 13 Minnesota coding proved invaluable in providing criteria on which to base electrocardiographic aspects of end points. Belgian study With the foregoing in mind, it is of interest to review the Belgian report by De Bacquer and colleagues. 3 The ECGs of 47 358 men and women participating in four Belgian epidemiological studies from the mid 1970s onwards have been combined in a form of meta analysis. Approximately 55% of the ECGs were coded by one individual while, for the remainder, a second reviewer assisted. The authors classified the ECGs according to various Minnesota Code categories-for example, major ECG abnormality was defined as pathological Q waves (codes 1-1 and 1-2), marked ST depression (codes 4-1 and 4-2) and/or T wave inversion (codes 5-1 and 5-2), bundle branch block (codes 7
In addition to electrocardiographic classification, a clinical classification was available for each patient. In particular, prevalent coronary heart disease was defined as angina pectoris or a positive history of acute myocardial infarction (self reported) or Q wave evidence (codes 1-1 and 1-2) of an old myocardial infarction on the resting ECG. Lifestyle characteristics were also recorded-for example, smoking habits, living alone, etc, while clinical data on hypertension, high total cholesterol (> 6.5 mmol/l or > 250 mg/dl), and Rose questionnaire 15 based angina pectoris were also noted.
Sex diVerences
Of particular interest is the fact that women have significantly more ST changes (2.6% v 2.3%) and T wave abnormalities (7.6% v 6.5%) on their resting ECG compared to men when adjustment is made for age, although the absolute diVerences in percentage terms were small (0.3% and 1.1%, respectively). This sex diVerence persisted in virtually all age deciles from 25 to 74 years. In a further analysis adjusted for age and other prognostic factors, only the ST changes remained significantly more common in women. Notwithstanding, the prevalence of angina is similarly higher in females than in males (6.0% v 5.0%) in all but the highest age group (65-74 years). In the same vein, the prevalence of coronary heart disease was found to be higher in women than men up to age 55 with a reversal of the situation above that age. On the contrary, the prevalence of a history of myocardial infarction was higher in males than in females (3.6% v 1.5%) with the exception of the youngest age range (25-34 years) where there was an increased prevalence in women (0.1% v 0%).
Although it is diYcult to reconcile all these data, somewhat similar results were found in the Whitehall II study. 16 In that study of 6895 male and 3413 female civil servants aged between 35 and 55 years on entry, men had a higher prevalence of "diagnostic" Q waves, equivocal Q waves, and pain suggestive of myocardial infarction than women; 4.0% of women and 2.4 % of men had self reported Rose questionnaire angina, while both men and women with angina had a higher prevalence of ST-T abnormalities compared to those without. The authors concluded that the "relationship between Rose angina and ischaemia (albeit imprecisely measured) appears weaker in men than in women".
In addition, 10 year follow up data 4 from a subset of the Belgian cohort support the hypothesis that women with ischaemic ECG changes defined as any of Minnesota  Codes 1-3, 4-1 to 4-3, 5-1 to 5-3 or 7-1-1 , have the same increased risk of death due to cardiovascular disease as men, with the multivariately adjusted risk ratio being 2.45 (95% confidence interval (CI) 1.70 to 3.53) for men and 2.16 (95% CI 1.30 to 3.58) for women.
Association of ECG abnormalities with lifestyle and coronary heart disease
In the study virtually all ECG abnormalities were linked with coronary heart disease. 3 Even those individuals with only minor ECG changes had a multivariately adjusted risk ratio of 1.28 (95% CI 1.13 to 1.44) of having coronary heart disease. This ties in with minor ECG ST-T changes (codes 4-2, 4-3, 5-2, 5-3) in WOSCOPS middle aged males having significant prognostic value in the prediction of fatal or non-fatal myocardial infarction both on a univariate and multivariate 17 basis. One of the strengths of the Belgian study is the ability to relate the prevalence of ECG abnormalities with the lifestyle characteristics. Ischaemic-like ECG changes were linked by the authors to obesity, diabetes, region, and employment status as well as age and overt coronary heart disease. The authors suggest that these are new findings-for example, being employed was linked with a lower prevalence of ischaemic ECG findings. Smoking had no eVect on the prevalences of ECG abnormalities.
It would have been of interest to know what the prevalence of silent myocardial infarction might have been, given that the lack of a history of acute myocardial infarction might have been related to the prevalence of abnormal Q waves on the resting ECG. The authors' results suggest that the prevalence of the relevant Minnesota Code abnormalities (1-1, 1-2) is in the order of 50% of the prevalence of acute myocardial infarction by history, except in one particular study-the Belgian jobstress project which studied the independent relation of perceived job stress with the incidence of fatal or non-fatal myocardial infarction. This study, which was the most recent, showed that there were 0.5% of ECGs with Q wave evidence suggestive of myocardial infarction in the absence of any relevant history both in men and women. On the other hand, using the authors' expanded definition of Q/QS abnormalities involving all codes 1, namely 1-1 to 1-3, there was a higher prevalence of Q/QS codes in women compared to a history of acute myocardial infarction (2.3% v 1.5%) and similarly in men up to 54 years, but a reversal in men thereafter, giving an overall higher prevalence of acute myocardial infarction than Q waves (3.6% v 3.2%) in men. These data make it diYcult to draw any firm conclusions on the prevalence of silent myocardial infarction.
Miscellaneous
The prevalence of left ventricular hypertrophy was found to be significantly higher in males than females (0.7% v 0.5%). It is suggested that inadequate criteria may in part be responsible for this finding, because criteria thresholds should be lower in women than men, but this is not the case in the Minnesota Code. The same cannot be said of right bundle branch block, the incidence of which was almost three times as high in males as in females, in all age ranges.
The prevalence of arrhythmias is also of interest. The most commonly studied arrhythmia, namely atrial fibrillation, was found to increase in prevalence as age increased, as is well known. 18 However, although the Belgian authors indicate that the overall prevalence of 0.55% in men and 0.33% in women is comparable with other studies, a prevalence of 2.7% in males and 1.53% in females in the 65-74 years age range is a little lower than found by others-for example, Feinberg and colleagues found a
